Legend Biotech (LEGN) Beginning Cash Balance (2019 - 2025)
Legend Biotech's (LEGN) quarterly Beginning Cash Balance came in at $278.9 million in Q4 2025, down 39.28% YoY from $459.3 million in Q4 2024, and down 39.28% on a QoQ basis from $459.3 million in Q4 2024.
Legend Biotech (LEGN) Beginning Cash Balance (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 7 years of Beginning Cash Balance data on file, last reported at $278.9 million in Q4 2025.
- Quarterly Beginning Cash Balance fell 39.28% year-over-year to $278.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 billion (down 17.67% YoY) and the FY2025 annual result came in at $286.7 million, down 77.56% from the prior year.
- Beginning Cash Balance retreated to $278.9 million in Q4 2025, from $459.3 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $963.5 million in Q4 2023 to a low of $278.9 million in Q4 2025.
- A 5-year average of $585.7 million and a median of $488.2 million in 2021 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2021 — Beginning Cash Balance surged 446.63% — and 2024, when it tumbled 52.33%.
- Tracing LEGN's Beginning Cash Balance over 5 years: stood at $338.3 million in 2021, then surged by 140.22% to $812.7 million in 2022, then rose by 18.55% to $963.5 million in 2023, then plunged by 52.33% to $459.3 million in 2024, then plunged by 39.28% to $278.9 million in 2025.
- The last three Beginning Cash Balance figures came in at $278.9 million (Q4 2025), $459.3 million (Q4 2024), and $963.5 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 278.90 Mn |
| Dec 31, 2025 | 278.90 Mn |
| Dec 31, 2024 | 459.30 Mn |
| Dec 31, 2024 | 459.30 Mn |
| Dec 31, 2023 | 963.47 Mn |
| Dec 31, 2023 | 963.47 Mn |
| Mar 31, 2023 | 786.03 Mn |
| Mar 31, 2023 | 786.03 Mn |
| Dec 31, 2022 | 812.73 Mn |
| Dec 31, 2022 | 812.73 Mn |
| Mar 31, 2022 | 688.94 Mn |
| Mar 31, 2022 | 688.94 Mn |
| Dec 31, 2021 | 338.33 Mn |
| Dec 31, 2021 | 338.33 Mn |
| Sep 30, 2021 | 488.22 Mn |
| Sep 30, 2021 | 488.22 Mn |
| Mar 31, 2021 | 455.69 Mn |
| Mar 31, 2021 | 455.69 Mn |
| Dec 31, 2020 | 449.38 Mn |
| Dec 31, 2020 | 449.38 Mn |